| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,400 |
16,989 |
$1.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,430 |
7,082 |
$483K |
| 99215 |
Prolong outpt/office vis |
755 |
708 |
$95K |
| 36415 |
Collection of venous blood by venipuncture |
12,446 |
11,703 |
$62K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,812 |
3,690 |
$49K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
553 |
542 |
$49K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
651 |
640 |
$41K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
668 |
243 |
$29K |
| 80061 |
Lipid panel |
1,899 |
1,842 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,388 |
2,345 |
$23K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
224 |
212 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
825 |
808 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
432 |
431 |
$14K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
197 |
188 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
444 |
444 |
$12K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
234 |
220 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
432 |
425 |
$12K |
| 80053 |
Comprehensive metabolic panel |
1,036 |
1,017 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
105 |
105 |
$11K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
665 |
652 |
$10K |
| 90686 |
|
994 |
972 |
$10K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
102 |
102 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
209 |
204 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
207 |
203 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
955 |
927 |
$9K |
| 99460 |
|
121 |
113 |
$8K |
| 85027 |
|
1,081 |
1,062 |
$7K |
| 86803 |
|
435 |
433 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
73 |
72 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
60 |
60 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
42 |
42 |
$6K |
| 91320 |
|
66 |
64 |
$6K |
| 90662 |
|
92 |
92 |
$5K |
| 82728 |
|
283 |
280 |
$4K |
| 86780 |
|
231 |
228 |
$3K |
| 81025 |
|
350 |
345 |
$3K |
| 92551 |
|
418 |
412 |
$3K |
| 90682 |
|
63 |
63 |
$3K |
| 0054A |
|
76 |
75 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
30 |
28 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
335 |
310 |
$3K |
| 90480 |
|
79 |
78 |
$3K |
| 90651 |
|
25 |
25 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
28 |
28 |
$3K |
| 90715 |
|
98 |
98 |
$2K |
| 0004A |
|
63 |
61 |
$2K |
| 0052A |
|
56 |
55 |
$2K |
| 99000 |
|
187 |
186 |
$2K |
| 82043 |
|
343 |
340 |
$2K |
| 0001A |
|
103 |
103 |
$2K |
| 80306 |
|
112 |
99 |
$2K |
| 99188 |
|
190 |
190 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
39 |
37 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
15 |
13 |
$2K |
| 90670 |
|
193 |
191 |
$2K |
| 0064A |
|
44 |
44 |
$2K |
| 96127 |
|
326 |
320 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
30 |
14 |
$1K |
| 0051A |
|
33 |
33 |
$1K |
| 99443 |
|
18 |
16 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
104 |
100 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
133 |
129 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
254 |
244 |
$1K |
| 0031A |
|
22 |
22 |
$880.22 |
| 0002A |
|
31 |
31 |
$842.71 |
| 81001 |
|
245 |
241 |
$841.76 |
| 81003 |
|
327 |
322 |
$797.42 |
| 90656 |
|
64 |
62 |
$784.48 |
| 99173 |
|
430 |
425 |
$740.59 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
30 |
30 |
$680.59 |
| 85018 |
|
246 |
245 |
$627.32 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
82 |
77 |
$582.39 |
| 0072A |
|
13 |
13 |
$547.15 |
| 86706 |
|
42 |
42 |
$517.29 |
| 0071A |
|
12 |
12 |
$508.37 |
| 87210 |
|
76 |
75 |
$499.93 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$482.28 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
15 |
15 |
$455.25 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
39 |
38 |
$395.60 |
| 87338 |
|
24 |
24 |
$379.67 |
| 36416 |
|
105 |
101 |
$349.04 |
| 83540 |
|
42 |
41 |
$310.16 |
| 96161 |
|
136 |
128 |
$246.45 |
| 82607 |
|
12 |
12 |
$204.96 |
| 82947 |
|
36 |
36 |
$161.70 |
| 87340 |
|
13 |
13 |
$153.97 |
| 84439 |
|
13 |
13 |
$134.58 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
20 |
20 |
$121.18 |
| 86140 |
|
13 |
13 |
$71.11 |
| 82570 |
|
16 |
16 |
$0.15 |
| 90723 |
|
70 |
68 |
$0.00 |
| 90648 |
|
123 |
121 |
$0.00 |